Cor Vasa 2011, 53(Suppl.):53-77 | DOI: 10.33678/cor.2011.194

Komorové arytmie

Jan Bytešník1, Petr Pařízek2, Dan Wichterle1, Josef Kautzner1, Petr Neužil3
1 Klinika kardiologie, IKEM, Praha
2 I. interní klinika LF UK a FN, Hradec Králové
3 Kardiologické oddělení, Nemocnice Na Homolce, Praha

Published: December 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bytešník J, Pařízek P, Wichterle D, Kautzner J, Neužil P. Komorové arytmie. Cor Vasa. 2011;53(Suppl.):53-77. doi: 10.33678/cor.2011.194.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. Circulation 2008;117:2820-2840. Go to original source...
    2. Táborský M, Kautzner J, Bytešník J, et al. Zásady pro implantace kardiostimulátorů, implantabilních kardioverterů-defibrilátorů a systémů pro srdeční resynchronizační léčbu 2009. Cor Vasa 2009;51:602-614. Go to original source...
    3. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Europace 2006;8:746-837. Go to original source... Go to PubMed...
    4. Aliot EM, Stevenson WG, Almendral-Garrote JM, et al. EHRA/HRS expert consensus on catheter ablation of ventricular arrhythmias. Europace 2009;11:771-817. Go to original source... Go to PubMed...
    5. Dickstein K, Vardas PE, Auricchio A, et al. 2010 focused update of ESC guidelines on device therapy in heart failure. Eur Heart J 2010;31:2677-2687. Go to original source... Go to PubMed...
    6. Moss AJ, Hall WJ, Cannom DS, et al., for the MADIT-CRT Trial Investigators. N Engl J Med 2009;361:1329-1338. Go to original source... Go to PubMed...
    7. Kautzner J, Bytešník J, Vančura V, et al. Poruchy srdečního rytmu. In: Klinická kardiologie. Vojáček J, Kettner J (eds.). Hradec Králové: Nucleus, 2009:239-335.
    8. Adamec J, Adamec R. Ekg podle Holtera. Elektrokardiografická interpretace. Praha: Galén, 2003;48-50, 105-107.
    9. Josephson ME. Clinical Cardiac Electrophysiology. Techniques and interpretation. 3rd edition. Philadelphia: Lippincott Williams and Wilkins, 2002:425-610, 658-863.
    10. Myerburg RJ, Kessler KM, Luceri RM, et al. Classification of ventricular arrhythmias based on parallel hierarchies of frequency and form. Am J Cardiol 1984;54:1355-1359. Go to original source...
    11. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001;104:2158-2163. Go to original source... Go to PubMed...
    12. Kong MH, Fonarow GC, Peterson ED, et al. Systematic review of the incidence of sudden cardiac death in the United States. J Am Coll Cardiol 2011;57:794-801. Go to original source... Go to PubMed...
    13. Moss AJ. MADIT-II and its implications. Eur Heart J 2003;24:16-18. Go to original source... Go to PubMed...
    14. Nichol G, Thomas E, Callaway CW, et al. Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA 2008;300:1423-1431. Go to original source... Go to PubMed...
    15. Kong MH, Fonarow GC, Peterson ED, et al. Systematic review of the incidence of sudden cardiac death in the United States. J Am Coll Cardiol 2011;57:794-801. Go to original source... Go to PubMed...
    16. Anderson MH. Risk assessment of ventricular tachyarrhythmias. Clinical approaches to tachyarrhythmias. Camm AJ. Armonk (eds.). NY: Futura Publishing Co., Inc., 1995:1-39.
    17. Horowitz LN. Ventricular arrhythmias: recognition and treatment. In: Nacarelli GV (ed.): Cardiac arrhythmias: a practical approach. Mount Kisco, NY: Futura Publishing Co., Inc., 1991:93-115.
    18. Bigger JT, Jr. Definition of benign versus malignant ventricular arrhythmias: targets for treatment: Am J Cardiol 1983;52:47C-54C. Go to original source...
    19. Morganroth J. Indications for antiarrhythmic suppression of ventricular arrhythmias: a definition of life-threatening ventricular arrhythmias. Am J Cardiol 1993;72:3A-7A. Go to original source...
    20. Mehta D, Curwin J, Gomes JA, Fuster V. Sudden death in coronary artery disease. Acute ischemia versus myocardial substrate. Circulation 1997;96:3215-3223. Go to original source... Go to PubMed...
    21. Crawford T, Cowger J, Desjardins B, et al. Determinants of postinfarction ventricular tachycardia. Circ Arrhythm Electrophysiol 2010;3:624-631. Go to original source... Go to PubMed...
    22. Lerman BB. Mechanism of outflow tract tachycardia. Heart Rhythm 2007;4:973-976. Go to original source... Go to PubMed...
    23. Firouzi M, Groenewegen WA. Gene polymorphisms and cardiac arrhythmias. Europace 2003;5:235-242. Go to original source... Go to PubMed...
    24. Larsen L, Markham J, Haffajee CI. Sudden death in idiopathic dilated cardiomyopathy: role of ventricular arrhythmia. Pacing Clin Electrophysiol 1993;16:1051-1059. Go to original source... Go to PubMed...
    25. Rubin AM, Morganroth J, Kowey PR. Ventricular premature depolarizations. In: Cardiac Arrhythmia. Mechanisms, Diagnosis and Management. Ed. Podrid PJ, Kowey PR. Baltimore: Williams and Wilkins 1995:891-906.
    26. Michelson EL, Morganroth J. Spontaneous variability of complex ventricular arrhythmia detected by long-term electrocardiopgaphic recording. Circulation 1980;61:690-695. Go to original source... Go to PubMed...
    27. Pratt CM, Slymen DJ, Wierman AM, et al. Analysis of the spontaneous variability of ventricular arrhythmias: consecutive ambulatory electrocardiographic recordings of ventricular tachycardia. Am J Cardiol 1985;56:67-72. Go to original source... Go to PubMed...
    28. Monserrat L, Elliot PM, Gimeno JR, et al. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. J Am Coll Cardiol 2003;42:873-9. Go to original source... Go to PubMed...
    29. Al-Khatib S, Stebbins AL, Califf RM, et al. Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial. Am Heart J 2003;145:515-521. Go to original source... Go to PubMed...
    30. Becker LB, Smith DW, Rhodes KV. Incidence of cardiac arrest: a neglected factor in evaluating survival rates. Ann Emerg Med 1993;22:86-91. Go to original source... Go to PubMed...
    31. Vreede-Swagemakers JJ, Gorgels AP, Dubois-Arbouw WI, et al. Out-of-hospital cardiac arrest in the 1990's: a population-based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol 1997;30:1500-1505. Go to original source... Go to PubMed...
    32. Myerburg RJ, Castellanos A. Cardiac arrest and sudden cardiac death. In: Braunwald E, ed. Heart disease: a textbook of cardiovascular medicine. New York: WB Saunders Publishing Co., 1997:742-779.
    33. Sans S, Kesteloot H, Kromhout D. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J 1997;18:1231-1248. Go to original source...
    34. Bayes de Luna A, Coumel P, Leclercq JF. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 1989;117:151-159. Go to original source... Go to PubMed...
    35. Volpi A, Cavalli A, Turato R, et al. Incidence and short-term prognosis of late sustained ventricular tachycardia after myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-3) data base. Am Heart J 2001;142:87-92. Go to original source... Go to PubMed...
    36. Kautzner J, Bytešník J. Tachykardie se širokým QRS komplexem: Přehled diferenciální diagnostiky. Prakt Lékař 1997;77:381-386.
    37. Brugada P, Brugada J, Mont L, et al. A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex. Circulation 1991;83:1649-1659. Go to original source... Go to PubMed...
    38. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation 1992;81(Suppl): I2-10.
    39. Chen X, Shenasa M, Borggreffe M, et al. Role of programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and documented sustained ventricular tachyarrhythmias: inducibility and prognostic value in 102 patients. Eur Heart J 1994;15:76-82. Go to original source... Go to PubMed...
    40. Goldberger JJ, Cain ME, Hohnloser SH, et al. AHA/ACC/HRS scientific statement of noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death. J Am Coll Cardiol 2008;52:1179-1199. Go to original source... Go to PubMed...
    41. Huikuri HV, Raatikainen MJP, Moerch-Joergensen RM, et al., for the CARISMA study group. Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction. Eur Heart J 2009;30:689-698. Go to original source... Go to PubMed...
    42. Huikuri HV, Tapanainen JM, Lindgren K, et al. Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. J Am Coll Cardiol 2003;42:652-658. Go to original source... Go to PubMed...
    43. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-1940. Go to original source... Go to PubMed...
    44. Komajda M, Jais JP, Reeves F, et al. Factors predicting mortality in idiopathic dilated cardiomyopathy. Eur Heart J 1990;11:824-831. Go to original source... Go to PubMed...
    45. Kelly P, Coats A. Variation in mode of sudden cardiac death in patients with idiopathic dilated cyrdiomyopathy. Eur Heart J 1997;18:879-880. Go to original source... Go to PubMed...
    46. Grimm W, Christ M, Bach J, et al. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy study. Circulation 2003;108:2883-2891. Go to original source... Go to PubMed...
    47. Grimm W, Christ M, Maisch B. Long runs of non-sustained ventricular tachycardia on 24-hour ambulatory electrogram predict major arrhythmic events in patients with idiopathic dilated cardiomyopathy. Pacing Clin Electrophysiol 2005;28:S207-S210. Go to original source... Go to PubMed...
    48. Fananapazir L, Chang AC, Epstein SE, et al. Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, haemodynamic, and electrophysiological findings. Circulation 1992;86:730-740. Go to original source... Go to PubMed...
    49. Maron BJ, McKenna WJ, Danielson GK, et al. ACC/ESC Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. Eur Heart J 2003;24:1965-1991. Go to original source... Go to PubMed...
    50. Kofflard MJM, Ten Cate FJ, van der Lee C, van Domburg RT. Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration. J Am Coll Cardiol 2003;41:987-993. Go to original source... Go to PubMed...
    51. McKenna WJ, Sadoul N, Slade AK, Saumarez RC. The prognostic significance of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy. Circulation 1994;90:3115-3117. Go to original source... Go to PubMed...
    52. Gimeno JR, Tomé-Esteban M, Lofiego C, et al. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy. Eur Heart J 2009;30:2599-2605. Go to original source... Go to PubMed...
    53. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Proposed modification of the Task Force criteria. Circulation 2010;121:1533-1541. Go to original source... Go to PubMed...
    54. Berder V, Vauthier M, Mabo P, et al. Characteristics and outcome in arrhythmogenic right ventricular dysplasia. Am J Cardiol 1995;75:411-414. Go to original source... Go to PubMed...
    55. Corrado D, Leoni L, Link MS, et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2003;108:3084-3091. Go to original source... Go to PubMed...
    56. Wichter T, Paul M, Wollmann C, et al. Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: Single-center experience of long-term follow-up and complications in 60 patients. Circulation 2004;109:1503-1508. Go to original source... Go to PubMed...
    57. Santangeli P, Pieroni M, Dello Russo A, et al. Noninvasive diagnosis of electroanatomic abnormalities in arrhythmogenic right ventricular cardiomyopathy. Circ Arrhyth Electrophysiol 2010;3: 632-638. Go to original source... Go to PubMed...
    58. McKoy G, Protonotarios N, Crosby A, et al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and wolly hair (Naxos disease). Lancet 2000;355:2119-2124. Go to original source... Go to PubMed...
    59. Dalal D, Nassir K, Bomma C, et al. Arrhythmogenic right ventricular dysplasia. A United States experience. Circulation 2005;112:3823-3832. Go to original source... Go to PubMed...
    60. Nugent AW, Daubeney PEF, Chondros P, et al. Tle epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 2003;348: 1639-1646. Go to original source... Go to PubMed...
    61. Murphy RT, Thaman R, Blanes JG, et al. Natural history and familial characteristics of isolated left ventricular noncompaction. Eur Heart J 2005;26:187-192. Go to original source... Go to PubMed...
    62. Kobza R, Jenni R, Erne P, et al. Implantable cardioverter-defibrillators in patients with left ventricular noncompaction. PACE 2008;31:461-467. Go to original source... Go to PubMed...
    63. Oechslin E, Attenhofer JCH, Rojas JR, et al. Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol 2000;36:493-500. Go to original source... Go to PubMed...
    64. Linhartová K. Restriktivní kardiomyopatie. In: Kardiomyopatie. Ed. Veselka J, Linhartová K, Zemánek D, et al. Praha: Galén, 2009:57-87.
    65. McCarthy RE, Kasper EK. A review of the amyloidoses that infiltrate the heart. Clin Cardiol 1998;21:547-552. Go to original source... Go to PubMed...
    66. Dispenzieri A, Kyle RA, Gertz MA, et al. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponin. Lancet 2003;361:1787-1789. Go to original source... Go to PubMed...
    67. Winters SL, Cohen M, Greenberg S, et al. Sustained ventricular tachycardia associated with sarcoidosis: Assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and implantable antitachycardia device. J Am Coll Cardiol 1991;18: 937-943. Go to original source... Go to PubMed...
    68. Paz HL, McCormick DJ, Kutalek S, Patchevsky A. The automated implantable cardiac defibrillator. Prophylaxis in cardiac sarcoidosis. Chest 1994;106:1603-1607. Go to original source... Go to PubMed...
    69. Lubitz SA, Goldberg SH, Mehta D. Sudden cardiac death in infiltrative cardiomyopathies: Sarcoidosis, scleroderma, amyloidosis, hemochromatosis. Progress Cardiovasc Dis 2008;51:58-73. Go to original source... Go to PubMed...
    70. Sachdev B, Takenaka T, Teraguchi H, et al. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation 2002;105:1407-1411. Go to original source... Go to PubMed...
    71. Whybra C, Kampmann C, Willers I, et al. Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes. J Inherit Metab Dis 2001;24:715-24. Go to original source... Go to PubMed...
    72. Patel MR, Cecchi F, Cizmarik M, et al. Cardiovascular events in patients with Fabry disease. J Am Coll Cardiol 2011;57:1093-1099. Go to original source... Go to PubMed...
    73. Elliott P, Andersson B, Arbustini F, et al. Classification of the cardiomyopathies: a position of statement from the European Society of Cardiology Working Group on myocardial and pericardial diseases. Eur Heart J 2008;29:270-276. Go to original source... Go to PubMed...
    74. Di Castelnuovo A, Costanzo S, Bagnardi V, et al. Alcohol dosing and total mortality in men and women an updated meta-analysis of 34 prospective studies. Arch Intern Med 2006;166:2437-2445. Go to original source... Go to PubMed...
    75. Meune C, Van Berlo JH, Anselme F, et al. Primary prevention of sudden death in patients with lamin A/C gene mutations. N Engl J Med 2006;354:209-210. Go to original source... Go to PubMed...
    76. Priori SG, Barhanin J, Hauer RNW, et al. Genetic and molecular basis of cardiac arrhythmias. Impact on clinical management. Eur Heart J 1999;20:174-195. Go to original source... Go to PubMed...
    77. Zareba W, Moss A, Schwartz P, et al. International Long QT Syndrome Registry Research Group: influence of the genotype on the clinical course of the long QT syndrome. N Engl J Med 1998;339:960-965. Go to original source... Go to PubMed...
    78. Fowler SJ, Napolitano C, Priori SG. When is genetic testing useful in patients suspected to have inherited cardiac arrhythmias? Curr Opin Cardiol 2010;25:37-45. Go to original source... Go to PubMed...
    79. Schwartz P, Priori S, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome. Gene-specific triggers for life-threatening arrhythmias. Circulation 2001;103:89-95. Go to original source... Go to PubMed...
    80. Priori SG, Schwartz PJ, Napolitano C, et al. Risk stratification in the long-QT syndrome. N Engl J Med 2003;348:1866-1874. Go to original source... Go to PubMed...
    81. Garrat CJ, Elliot P, Behr E, et al. Heart Rhythm UK position statement on clinical indications for implantable cardioverter defibrillators in adult patients with familial sudden cardiac death syndromes. Europace 2010;12:1156-1175. Go to original source... Go to PubMed...
    82. Zareba W, Moss AJ, Daubert JP, et al. Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol 2003;14:337-341. Go to original source... Go to PubMed...
    83. Gussak I, Brugada P, Brugada J, et al. Idiopathic short QT interval: A new clinical syndrome? Cardiology 2000;94:99-102. Go to original source... Go to PubMed...
    84. Brugada R, Hong K, Dumaine R, et al. Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 2003;108:3092-3096. Go to original source... Go to PubMed...
    85. Gollob MH, Redpath CJ, Roberts JD. Tle short QT syndrome. Proposed diagnostic criteria. J Am Coll Cardiol 2011;57:802-812. Go to original source... Go to PubMed...
    86. Brugada P, Brugada J. Right bundle branch block, persistent ST-segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992;20:1391-1396. Go to original source... Go to PubMed...
    87. Brugada R, Brugada J, Antzelevitch C, et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 2000;101:510-515. Go to original source... Go to PubMed...
    88. Brugada J, Brugada R, Brugada P. Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation 2003;108:3092-3096. Go to original source... Go to PubMed...
    89. Probst V, Veltmann C, Eckardt L, et al. Long-term prognosis of patients diagnosed with Brugada syndrome. Results from the FINGER Brugada syndrome registry. Circulation 2010;121:635-643. Go to original source... Go to PubMed...
    90. Klatsky AL, Oehm R, Cooper RA, et al. The early repolarization normal variant electrocardiogram: correlates and consequences. Am J Med 2003;115:171-177. Go to original source... Go to PubMed...
    91. Tikkanen JT, Anttonen O, Juhani Junttila M, et al. Long-term outcome associated with early repolarization on electrocardiography. N Engl J Med 2009;361:2529-2537. Go to original source... Go to PubMed...
    92. Haissaguerre M, Derval N, Sacher F, et al. Sudden cardiac arrest associated with early repolarization. N Engl J Med 2008;358:2016-2023. Go to original source... Go to PubMed...
    93. Cappato R, Furlanelo F, Giovinazzo V, et al. J wave, QRS slurring, and ST elevation in athletes with cardiac arrest in the absence of heart disease. Marker of risk or innocent bystander? Circ Arrhythm Electrophysiol 2010;3: 305-411. Go to original source... Go to PubMed...
    94. Gussak I, Antzelevitch C. Early repolarization syndrome: clinical characteristics and possible cellular and ionic mechanisms. J Electrocardiol 2000;33:299-309. Go to original source... Go to PubMed...
    95. Zicha S, Xiao I, Stafford S, et al. Transmural expession of transient outward potassium current subunits in normal and failing canine and human hearts. J Physiol 2004;561:735-748. Go to original source... Go to PubMed...
    96. Patel RB, Ng J, Reddy V, et al. Early repolarization associated with ventricular arrhythmias in patients with chronic coronary artery disease. Circ Arrhythm Electrophysiol 2010;3:489-495. Go to original source... Go to PubMed...
    97. Lahat H, Eldar M, Levy-Nissenbaum E, et al. Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: Clinical features and assignment of the disease gene to chromosome 1p13-21. Circulation 2001;103:2822-2827. Go to original source... Go to PubMed...
    98. Priori SG, Napolitano C, Memmi M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002;106:69-74. Go to original source... Go to PubMed...
    99. Napolitano C, Priori SG. Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2007;4:675-678. Go to original source... Go to PubMed...
    100. Novotný T, Kubuš P, Vít P, et al. Klinická charakteristika tří českých rodin s katecholaminergní polymorfní komorovou tachykardií a pilotní výsledky mutační analýzy genu RyR2. Cor Vasa 2010;52:39-42. Go to original source...
    101. Leenhardt A, Glaser E, Burguera M, et al. Short-coupled variant of torsade de pointes: a new electrocardiographic entity in the spectrum of idiopathic ventricular tachyarrhythmias. Circulation 1994;89:206-215. Go to original source... Go to PubMed...
    102. Janousek J, Paul T, Bartakova H. Role of late potentials in identifying patients at risk for ventricular tachycardia after surgical correction of congenital heart disease. Am J Cardiol 1995;75:146-150. Go to original source... Go to PubMed...
    103. Natale A, Raviele A, Al-Ahmad A, et al. Venice Chart International Consensus Document on Ventricular Tachycardia/Ventricular Fibrillation Ablation. J Cardiovasc Electrophysiol 2010;21:339-379. Go to original source... Go to PubMed...
    104. Chinushi M, Aizawa Y, Kitazawa H, et al. Successful radiofrequency catheter ablation for macroreentrant ventricular tachycardia in a patient with tetralogy of Fallot after corrective surgery. PACE 1995;18: 1713-1716. Go to original source... Go to PubMed...
    105. Liberthson RR. Sudden death from cardiac causes in children and young adults. N Engl J Med 1996;334:1039-1044. Go to original source... Go to PubMed...
    106. Fontaine G, Fornes P, Fontaliran F, et al. Myocarditis as a cause of sudden death response. Circulation 2001;103:12. Go to original source... Go to PubMed...
    107. Chiale PA, Halperin MS, Nau GJ, et al. Malignant ventricular arrhythmias in chronic chagasic myocarditis. PACE 1995;18:162-172. Go to original source...
    108. Tai YT, Lau CP, Fong PC, et al. Incessant automatic ventricular tachycardia complicating acute coxsackie B myocarditis. Cardiology 1992;80:339-344. Go to original source... Go to PubMed...
    109. Cooper LT, Jr. Giant cell myocarditis: diagnosis and treatment. Herz 2000;25:291-298. Go to original source... Go to PubMed...
    110. Bartůněk P. Lymeská karditida. In: Kardiologie. Ed. Aschermann M, et al. Praha: Galén, 2004:847-851.
    111. Rassi A, Jr., Rassi A, Little WC. Chagas' heart disease. Clin Cardiol 2000;23:883-889. Go to original source... Go to PubMed...
    112. Muratore C, Rabinovich R, Iglesias R, et al. Implantable cardioverter-defibrillators in patients with Chagas' disease: are they different from patients with coronary disease? Pacing Clin Electrophysiol 1997;20: 194-197. Go to original source... Go to PubMed...
    113. Maione S, Valentin G, Giunta A, et al. Cardiac involvment in rheumatoid arthritis. Cardiology 1993;83:234. Go to original source... Go to PubMed...
    114. MERIT-HF study group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-2007. Go to original source...
    115. Bardy GH, Lee KL, Mark DB, et al., for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-237. Go to original source... Go to PubMed...
    116. Bristow MR, Saxon LA, Boehmer J, et al., for COMPANION Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350: 2140-2150. Go to original source... Go to PubMed...
    117. Cleland JGF, Daubert JC, Erdmann E, et al., for CARE-HF Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549. Go to original source... Go to PubMed...
    118. Moss AJ, Hall WJ, Cannom DS, et al., for the MADIT-CRT Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-1338. Go to original source... Go to PubMed...
    119. Zareba W, Klein H, Cygankiewicz I, et al. Effectiveness of cardiac resynchronization therapy by QRS morphology in the Multicenter Automatic Defibrillator Implantation Trial - Cardiac Resynchronization Therapy (MADIT-CRT). Circulation 2011;123:1061-1072. Go to original source... Go to PubMed...
    120. Málek I, Marek T. Dlouhodobá péče o nemocné po ortotopické transplantaci srdce. In: Transplantace srdce. Ed. Pirk J, Málek I, et al. Praha: Karolinum, 2008:115-161.
    121. Mills RM, Jr., Naftel DC, Kirklin JK, et al., and the transplant research database. Heart transplant rejection with hemodynamic compromise: a multi-institutional study of the role of endomyocardial cellular infiltrate. J Heart Lung Transplant 1997;16:813-821.
    122. Grimm M, Rinaldi M, Zonan NA, et al. Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients. A large European trial. Am J Transplant 2006;6:1387-1397. Go to original source... Go to PubMed...
    123. Viskin S, Belhassen B. Idiopathic ventricular fibrillation. Am Heart J 1990;120:661-671. Go to original source... Go to PubMed...
    124. Priori SG, Crotti L. Idiopathic ventricular fibrillation. Cardiac Electrophysiol Rev 1999;3:198-201. Go to original source...
    125. Chen Q, Kirsch GE, Zhang D, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998;392:293-294. Go to original source... Go to PubMed...
    126. Priori SG, Borggrefe M, Camm AJ, et al. Role of the implantable defibrillator in patients with idiopathic ventricular fibrillation. Data from the UCARE International Registry. PACE 1995;18:799.
    127. The beta-blocker heart attack study group. The beta-blocker heart attack trial. JAMA 1981;246:2073-2074. Go to PubMed...
    128. The Norwegian Multicenter Study Group: Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981;304:801-807. Go to original source... Go to PubMed...
    129. Hjalmarson Ĺ, Elmfeldt D, Herlitz J, et al. Effect on mortality of metoprolol in acute myocardial infarction: a double-blind randomised trial. Lancet 1981;2:823-827. Go to original source... Go to PubMed...
    130. Singh BN, Jewitt DE. Beta-adrenoreceptor blocking drugs in cardiac arrhythmias. Cardiovasc Drugs 1997;2:119-159.
    131. Packer M, Coats AJS, Fowler MB, et al.; for the carvedilol prospective randomized cumulative survival study group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651-1658. Go to original source... Go to PubMed...
    132. Poole-Wilson PA, Swednerg K, Cleland JCF, et al., for the COMET investigators Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the carvedilol or metoprolol european trial (COMET): randomised controlled trial. Lancet 2003;362:7-13. Go to original source... Go to PubMed...
    133. Echt DS, Leibson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991;324:781-788. Go to original source... Go to PubMed...
    134. Amiodarone Trials Meta-Analysis Investigators: Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Lancet 1997;350:1417-1424.
    135. International Liaison Committee on Resuscitation. 2005 International consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendastion. Resuscitation 2005;67:181-341. Go to original source... Go to PubMed...
    136. Garza AG, Gratton MC, Salomone JA, et al. Improved patient survival using a modified resuscitation protocol for out-of-hospital cardiac arrest. Circulation 2009;119:2597-2605. Go to original source... Go to PubMed...
    137. Priori SG, Bossaert LL, Chamberlain DA, et al. ESC-ERC recommendations of the use of automated external defibrillators (AEDs) in Europe. Eur Heart J 2004;25:437-445. Go to original source... Go to PubMed...
    138. Jost D, Degrange H, Verret C, et al.; DEFI 2005. A randomized controlled trial of the effect of automated external defibrillator cardiopulmonary resuscitation protocol on outcome from out-of-hospital cardiac arrest. Circulation 2010;121:1614-1622. Go to original source... Go to PubMed...
    139. Alexander JH, Granger CB, Sadowski Z, et al.; for the GUSTO-I and GUSTO-IIb Investigators. Proplylactic lidocaine use in acute myocardial infarction: incidence and outcomes from from two international trials. Am Heart J 1999;137:799-805. Go to original source... Go to PubMed...
    140. Wyman MG, Wyman M, Cannom DS, Criley JM. Prevention of primary ventricular fibrillation in acute myocardial infarction with prophylactic Lidocaine. Am J Cardiol 2004;94:541-551. Go to original source... Go to PubMed...
    141. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-1583. Go to original source... Go to PubMed...
    142. Connolly SJ, Gent M, Roberts RS, et al. Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-1302. Go to original source... Go to PubMed...
    143. Kuck KH, Cappato R, Siebels J, et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. The Cardiac Arrest Hamburg (CASH) Study. Circulation 2000;102:748-754. Go to original source... Go to PubMed...
    144. Connolly SJ, Hallstrom AP, Cappato R, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. Eur Heart J 200021:2071-2078. Go to original source... Go to PubMed...
    145. Stevenson WG, Khan H, Sager P, et al. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation 1993;88:1647-1670. Go to original source... Go to PubMed...
    146. Marchlinski FE, Callans DJ, Gottlieb CD, Zado E. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation 2000;101:1288-1296. Go to original source... Go to PubMed...
    147. Kautzner J, Čihák R, Peichl P, et al. Catheter ablation of ventricular tachycardia following myocardial infarction using three-dimensional electroanatomical mapping. PACE 2003;26:342-347. Go to original source... Go to PubMed...
    148. Reddy VY, Neuzil P, Taborsky M, Ruskin JN. Short-term results of substrate mapping and radiofrequency ablation of ischemic ventricular tachycardia using a saline-irrigated catheter. J Am Coll Cardiol 2003;41:2228-2236. Go to original source... Go to PubMed...
    149. Sosa E, Scanavacca M, d'Avila A, Pillegi F. A new technique to perform epicardial mapping in the electrophysiology laboratory. J Cardiovasc Electrophysiol 1996;7:531-536. Go to original source... Go to PubMed...
    150. Sosa E, Scanavacca M, d'Avila A, et al. Nonsurgical transthoracic epicardial catheter ablation to treat recurrent ventricular tachycardia occuring late after myocardial infarction. J Am CollCardiol 2000;35:1442-1449. Go to original source... Go to PubMed...
    151. Shumway SJ, Johnson EM, Svendsen CA, et al. Surgical management of ventricular tachycardia. Ann Thorac Surg 1997;63:1589-1591. Go to original source... Go to PubMed...
    152. Wellens F, Geelen P, Demirsay E, et al. Surgical treatment of tachyarrhythmias due to postinfarction left ventricular aneurysm with endoaneurysmorrhaphy and cryoablation. Eur J Cardiothorac Surg 2002;22:771-776. Go to original source... Go to PubMed...
    153. Pirk J, Bytesnik J, Kautzner J, et al. Surgical ablation of post-infarction ventricular tachycardia guided by mapping in sinus rhythm: long term results. Eur J Cardiothorac Surg 2004;26:323-329. Go to original source... Go to PubMed...
    154. Braunschweig F, Boriani G, Bauer A, et al. Management of patients receiving implantable cardiac defibrillator shocks. Europace 2010;12:1673-1690. Go to original source... Go to PubMed...
    155. Carbucchio C, Santamaria M, Trevisi N, et al. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study. Circulation 2008;117:462-469. Go to original source... Go to PubMed...
    156. Katritsis DG, Camm AJ. Nonsustained ventricular tachycardia: where do we stand? Eur Heart J 2004;25:1093-1099. Go to original source... Go to PubMed...
    157. Buxton AE, Lee KL, Fischer JD, et al. A randomized study of the prevention of suddden death in patients with coronary artery disease (MUSTT). N Engl J Med 1999;341:1882-1890. Go to original source... Go to PubMed...
    158. Andresen D, Steinbeck G, Brüggeman T, et al. Risk stratification following myocardial infarction in the thrombolytic era. A two-step strategy using noninvasive and invasive methods. J Am Coll Cardiol 1999;33:131-138. Go to original source... Go to PubMed...
    159. Bailey JJ, Berson A, Handelsman H, Hodges M. Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction. J Am Coll Cardiol 2001;38:1902-1911. Go to original source... Go to PubMed...
    160. Buxton AE, Lee KL, DiCarlo L, et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. N Engl J Med 2000;342:1937-1945. Go to original source... Go to PubMed...
    161. Moss A. Implantable cardioverter defibrillator therapy: the sickest patients benefit the most. Circulation 2000;101:1638-1640. Go to original source... Go to PubMed...
    162. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883. Go to original source... Go to PubMed...
    163. Wilber DJ, Zareba W, Hall WJ, et al. Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation 2004;109:1082-1084. Go to original source... Go to PubMed...
    164. Hohnloser SH, Kuck KH, Dorian P, et al.; DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction: N Engl J Med 2004;351:2481-2488. Go to original source... Go to PubMed...
    165. Steinbeck G, Andresen D, Seidl K, et al., for the IRIS Investigators. Defibrillator implantation early after myocardial infarction. N Engl J Med 2009;361:1427-1436. Go to original source... Go to PubMed...
    166. Dorian P, Hohnloser SH, Thorpe KE, et al. Mechanisms underlying the lack of effect of implantable cardioverter-defibrillator therapy on mortality in high-risk patients with recent myocardial infarction: insights from the Defibrillation in Acute Myocardial Infarction Trial (DINAMIT). Circulation 2010;122:2645-2652. Go to original source... Go to PubMed...
    167. Pouleur AC, Barkoudah E, Uno H, et al.; for the VALIANT Investigators. Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. Circulation 2010;122:597-602. Go to original source... Go to PubMed...
    168. Goldenberg I, Gillespie J, Moss AJ, et al. Long-term benefit of primary prevention with an implantable cardioverter defibrillator. An eight year follow-up study of the Multicenter automatic defibrillator trial II. Circulation 2010;122:1265-1271. Go to original source... Go to PubMed...
    169. Paganelli K, Barnay P, Imbert-Joscht I, et al. Influence of residual myocardial ischemia on induced ventricular arrhythmias following a first acute myocardial infarction. Eur Heart J 2001;22:1931-1937. Go to original source... Go to PubMed...
    170. Wichterle D, Šimek J, Camm J, Malik M. Predictive characteristics of Holter-based postinfarction risk stratifiers appear superior to electrophysiological testing. PACE 2005;28(suppl 1):S182-S186. Go to original source... Go to PubMed...
    171. Tabib A, Loire R, Chalabreysse L, et al. Circumstances of death and gross and microscopic observations in a series of 200 cases of sudden cardiac death associated with arrhythmogenic right ventricular cardiomyopathy and/or dysplasia. Circulation 2003;108:3000-3005. Go to original source... Go to PubMed...
    172. Wilkoff BL, Aurricchio A, Brugada J, et al. HRS/EHRA expert consensus on the monitoring of cardiac electronic implantable devices (CIEDs): description of techniques indications, personnel, frequency, and ethical considerations. Heart Rhythm 2008;5:907-925. Go to original source... Go to PubMed...
    173. Poole JE, Gleva MJ, Mela T, et al., for the REPLACE Registry Investigators. Complication rates associated with pacemaker or implantble cardioverter-defibrillator generator replacements and upgrade procedures. Results from the REPLACE Registry. Circulation 2010;122:1553-1561. Go to original source... Go to PubMed...
    174. Moss AJ, Greenberg H, Case RB, et al.; for the MADIT-II Research Group. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 2004;110:3760-3765. Go to original source... Go to PubMed...
    175. Garcia FC, Valles E, Dhruvakumar S, Marchlinski F. Ablation of ventricular tachycardia. Herzschrittmacherther Elektrophysiol 2007;18:225-233. Go to original source... Go to PubMed...
    176. D'Avila A. Epicardial catheter ablation of ventricular tachycardia. Heart Rhythm 2008;5(Suppl):S73-S75. Go to original source... Go to PubMed...
    177. Oakley C, Child A, Jung B, et al. (Task Force Members). Expert consensus document on management of cardiovascular disease during pregnancy. Eur Heart J 2003;24:761-781. Go to original source... Go to PubMed...
    178. Tau HL, Lie KI. Treatment of tachyarrhythmias during pregnancy and lactation. Eur Heart J 2001;22:458-464. Go to original source... Go to PubMed...
    179. Král J. Kardiovaskulární onemocnění v těhotenství. In: Kardiologie. Aschermann M, et al. (eds.). Praha: Galén 2004:1357-1368.
    180. Natale A, Davidson T, Geiger MJ. Implantable cardioverter defibrillators and pregnancy. A safe combination? Circulation 1997;96:2808-2812. Go to original source... Go to PubMed...
    181. Corrado D, Basso C, Rizzoli G, et al. Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 2003;42:1959-1963. Go to original source... Go to PubMed...
    182. Maron BJ, Doerer JJ, Haas TS, et al. Sudden deaths in young competitive athletes. Analysis of 1866 deaths in the United States, 1980-2006. Circulation 2009;119:1085-1092. Go to original source...
    183. Heidbucherl H, Hoogsteen J, Fagard L, et al. High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias. Eur Heart J 2003;16:1474-1480. Go to original source... Go to PubMed...
    184. Maron BJ, Zipes DP. Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities - general considerations. J Am Coll Cardiol 2005;45:1318-1321. Go to original source... Go to PubMed...
    185. Pelliccia A, Maron BJ. Preparticipation cardiovascular evaluation of the competitive athlete: perspectives from the 30-year Italian experience. Am J Cardiol 1995;75:827-829. Go to original source... Go to PubMed...
    186. Pelliccia A, Zipes DG, Maron BJ. Bethesda Conference # 36 and tle European Society of Cardiology consensus recommendations revisited. A comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 2008;52:1990-1996. Go to original source... Go to PubMed...
    187. Kölbel F, Bytešník J. Kardiovaskulární systém ve stáří. In: Kardiologie. Aschermann M, et al. (eds.). Praha: Galén, 2004:1343-1355.
    188. Fleg JL, Kennedy HL. Cardiac arrhythmias in a healthy elderly population: detection by 24-hour ambulatory electrocardiography. Chest 1982;81:302-307. Go to original source... Go to PubMed...
    189. Ornato JP, Peberdy MA, Tadler SC, et al. Factors associated with the occurrence of cardiac arrest during hospitalization for acute myocardial infarction in the second national registry of myocardial infarction in the U.S. Resuscitation 2001;48:117-123. Go to original source... Go to PubMed...
    190. Panotopoulos PT, Axtell K, Anderson AJ, et al. Efficacy of the implantable cardioverter - defibrillator in the elderly. J Am Coll Cardiol 1997;29: 556-560. Go to original source... Go to PubMed...
    191. Geelen P, Lorga FA, Primo J, et al. Experience with implantable cardioverter - defibrillator therapy in elderly patients. Eur Heart J 1997;18: 1339-1342. Go to original source... Go to PubMed...
    192. Eckart RE, Gula LJ, Reynolds MR, et al. Mortality following defibrillator implantation in patients with renal insufficiency. J Cardiovasc Electrophysiol 2006;17:940-943. Go to original source... Go to PubMed...
    193. Isner JM, Roberts WC, Heymsfield SB, et al. Anorexia nervosa end sudden death. Ann Intern Med 1985;102:49-52. Go to original source... Go to PubMed...
    194. Swenne I, Larsson PT. Heart risk associated with weight loss in anorexia nervosa and eating disorders: risk factors for QTc interval prolongation and dispersion. Acta Paediatr 1999;88:304-309. Go to original source... Go to PubMed...
    195. Haddad PM, Anderson IM. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs 2002;62:1649-1671. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes